News Features Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions? Todd Neale October 22, 2025
News Features GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix? Todd Neale November 13, 2024
News Features Going Solo: Can TAVI Be Performed Without a Surgical Safety Net? Michael O'Riordan January 22, 2024
News Features As COVID-19 Vaccine Boosters Roll Out to Younger Kids, Will Myocarditis Cases Rise? Todd Neale January 13, 2022
News Features Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay? Todd Neale December 09, 2021
News Features Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle Shelley Wood October 08, 2021
News Features The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive Todd Neale February 08, 2021
News Features Playing With Heart: Returning Kids Safely to Sport in the COVID-19 Era Todd Neale November 02, 2020
News Features COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions Shelley Wood July 20, 2020
News Features Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms Caitlin E. Cox April 23, 2020
News Features Obesity and COVID-19: Theories and Blame Fill the Scientific Void Shelley Wood April 21, 2020
News Features ‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry Michael O'Riordan January 10, 2020
News Features Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses Shelley Wood December 23, 2019
News Features Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too Michael O'Riordan December 18, 2019
News Features ESC Heart Failure 2019 At the ESC Heart Failure Congress, Some COAPT Converts—and Some Pushback Shelley Wood May 30, 2019
News Features ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging Michael O'Riordan March 23, 2018